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Insufficiency fractures of the knee, ankle, and foot in 
rheumatoid arthritis: A case series and case-control study
Introduction
Rheumatoid arthritis (RA) is a chronic, progressive, systemic inflammatory disease leading to substantial 
pain, disability, and other morbidities (1). Patients with RA are at an increased risk of osteoporosis and oste-
oporotic fractures, aggravated by factors such as inactivity or corticosteroid therapy (2-5). The occurrence 
of spontaneous extremity fractures in RA, including stress and insufficiency fractures, has only occasionally 
been reported in the medical literature, primarily  in the form of case reports or case series (6-14). Pub-
lished epidemiological studies on the occurrence of fractures in RA are almost entirely based on the use 
of conventional radiography as the diagnostic imaging modality (2, 15). However, MRI has been shown to 
be considerably more sensitive in the detection of occult fractures, which commonly can be overlooked 
under conventional radiography (16). An insufficiency fracture occurs when the mechanical strength of a 
bone is reduced to the point where it breaks by a given physiological stress that would normally not lead to 
a fracture in a healthy bone. Reduced bone strength can be typically due to generalized osteopenia in the 
skeleton as observed in osteoporosis, osteomalacia, or osteogenesis imperfecta, as well as due to localized 
osteopenia caused by demineralization in a limb due to inactivity (7).
RA patients frequently contact rheumatology clinics due to an increase in their joint pain or emergence 
of new articular or periarticular pain at a new site, despite their ongoing treatment. Most often, increased 
arthritis disease activity is the cause of such pain; however, secondary osteoarthritis and joint deformities 
are other possible causes and therefore should be considered in differential diagnosis. The treatment 
of joint pain in such patients will usually include joint injections with steroids, adding or increasing 
the dose of  concomitant antirheumatic medications, including nonsteroidal anti-inflammatory drugs 
and orthoses. Pain in the hips or back is unlikely to be confused with arthritis disease activity because 
RA predominantly attacks the peripheral joints. However, pain, swelling, and disability caused by in-
sufficiency fractures of the lower extremities may be easily mistaken for rheumatoid synovitis (9). Plain 
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Abstract
Objective: To evaluate cases of insufficiency fractures verified by magnetic resonance imaging (MRI) of 
the knee, ankle, and foot in patients with rheumatoid arthritis (RA) cared for in our clinic over an 8-year 
period, to identify possible risk factors, and to test these in a case-control study.
Methods: All patients in the rheumatology clinic with RA were registered prospectively in the data-
base, DANBIO. All MRIs ordered from the clinic were registered and coded according to the anatom-
ical region. We were thus able to retrieve all patients with RA and performed an MRI of the knee or 
ankle/foot. The patients with fractures constituted the case series, and the patients without fractures 
constituted the control group.
Results: The RA clinic population comprised 1,624 patients who underwent a total of 70 MRIs. Case 
series: 39 insufficiency fractures were identified in 32 patients; 93% were women, and the median 
age was 68 years (range 33-89 years). Half of the patients had a T score >-2.5. The case control group 
without fractures comprised 38 patients; 74% were women, and the median age was 62 years (range 
32-84 years). In the case series, 20 patients experienced later additional episodes of insufficiency frac-
tures in the knee, ankle, or foot.
Conclusion: Insufficiency fractures of the knee, ankle, and foot are a significant cause of pain and 
long-lasting disability in RA. Recurrent fractures are common. Diagnosis is often delayed and con-
fused with arthritic activity. Conventional radiography and DEXA scan are often normal. Older age, 
female gender, radiological erosions in hand/wrist, and treatment with methotrexate were all signifi-
cantly associated with fractures.
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radiographs taken initially may not reveal the 
fracture (8, 10). Therefore, RA patients, those 
presenting with local pain in the knee, ankle, 
or foot, particularly if a single periarticular site 
is involved and those who also have normal 
articular findings on ultrasound examination, 
should be examined with an MRI to confirm 
or rule out a diagnosis of an insufficiency frac-
ture, irrespective of the absence of a trauma 
history or the presence of  normal findings on 
conventional radiography. 
The aim of this study was to review MRI-veri-
fied cases of insufficiency fractures of the knee, 
ankle, and foot in patients with RA cared for in 
our clinic over an 8-year period and to identify 
possible risk factors.
Methods
Study design 
The study was designed as a retrospective 
case-control study based on prospectively reg-
istered clinical data.
Patients and setting
The clinic of rheumatology, North Denmark 
Region Hospital, Hjørring cares for around 
1,200 RA patients, and, since 2010, all have 
been prospectively registered twice a year 
in the clinical database DANBIO (17). Patients 
have access to clinical consults “on demand” 
without waiting times or costs. Treatment 
of the patients follows national guidelines, 
which is similar to the European League 
Against Rheumatism/American College of 
Rheumatology (EULAR/ACR) guidelines. The 
treatment costs are almost entirely free of 
charge for the patients. Ultrasonic scanners 
are readily available to all physicians in the 
entire clinic. The C-reactive protein (CRP) and 
Disease-Activity-Score-28 joints with CRP 
(DAS28crp) values used were the last values 
recorded before the estimated fracture date. 
The body mass index of patients was routinely 
recorded when ordering an MRI.
The inclusion criteria for both the case series and 
the controls were an RA diagnosis and a first-time 
MRI of the knee or ankle/foot in the 8-year period 
from 2010 to 2017. The only exclusion criterion 
was evident high-energy fractures initially diag-
nosed and treated by orthopedic surgeons. The 
case series patients had a fracture of the distal fe-
mur, tibia, fibula, talus, calcaneus, and navicular or 
metatarsal bones detected with an MRI.
The case-control group comprised the patients 
without fractures (Figure 1). The control group 
had the same RA diagnosis and were treated 
by the same staff and with the same treatment 
principles. In addition, the indications for MRI 
were largely similar for both groups of patients 
(unexplained local pain in the knee, ankle, or 
foot despite clinical, ultrasonic, and conven-
tional radiographic examinations).
All included patients were unique, that is, if 
more than one fracture episode occurred in 
the 8-year period, only the first episode was 
included.
Statistical analysis
Descriptive statistics of the study popula-
tions was presented as medians + quartiles, 
where data were nonnormally distributed. 
Test for normality was performed using the 
Kolmogorov-Smirnoff test for normality. The 
Mann-Whitney U test was used for comparison 
of clinical variables and the Fisher’s exact test 
was performed to test the risk contingency for 
fractures amongst patients suffering from oste-
oporosis in comparison with patients not suf-
fering from osteoporosis. P values <0.05 were 
considered statistically significant. Statistical 
analysis was carried out after the collection of 
patient data. After testing for normality, a final 
decision regarding the remaining statistical 
testing was done. All statistical analysis was 
carried out using Graphpad Prism 7.0 (Graph-
pad; San Diego, CA, USA).
Osteoporosis
DEXA scans examining the lumbar spine and 
one hip were obtained, and the result was re-
ported as a T score. DEXA scans were not sys-
tematically ordered in the clinic, and therefore, T 
scores were missing for some patients. Some of 
the patients were referred to DEXA scan by their 
general practitioner, and others were invited by 
a local private clinical trial center. The results of 
these DEXA scans were not always available to 
us because of incompatibility with the results 
given on print paper and the hospital’s new 
electronic patient record IT system. However, 
we could manage all patients for any prescribed 
pharmaceutical treatment for osteoporosis.
MRI
Access to MRI was available, with an average 
waiting time between 2 and 6 weeks. The hos-
pital IT system codes MRI procedures by both 
anatomical localization and by the requesting 
clinic. Thus, it is possible to retrieve all MRI 
scans of the knee and ankle/foot in patients 
with RA by combining DANBIO and the hos-
pital IT systems. MRIs of the ankle also include 
MRIs of the foot. After retrieving the patients, 
both their medical records and MRIs were sys-
tematically reviewed.
Ethical considerations
According to the Danish legislation, the reg-
istration and publication of data from clini-
cal registries, or quality assurance studies, do 
not require consent of patients or approval 
from the Ethics Committees. The study was 
approved on October 1, 2018 by the North 
Jutland Region (research registration) with ID 
number 2018-155.
Results
Description of study population characteristics 
and fracture incidence rate
A total of 1,624 unique patients with RA received 
treatment during 2010 to 2017. The selection of 
Main Points
• Lower extremity insufficiency fractures 
in patients with rheumatoid arthritis are 
common.
• Most patients will encounter new or re-
current fractures within a few years.
• Fracture diagnoses are often delayed 
and only visible after MRI.
• Elderly female patients are at particular risk.
• MRI is recommended even if conventional 
radiography and DEXA scans are normal.
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Figure 1. Patient selection for the case series 
and the case-control group, both with RA and 
unexplained local pain in the knee, ankle, or 
foot. In total, 1,624 unique patients with RA 
were treated in the clinic during 2010-2017. 
The lower two boxes define the case series 
and the case-control group. MRI ankle in-
cludes foot. 
RA: rheumatoid arthritis; MRI: magnetic resonance 
imaging.
patients for the case series and the case-control 
group is shown in Figure 1. The number of MRIs 
performed for the knees was 32 with 10 frac-
tures identified, and for the foot/ankle, it was 38 
with 22 fractures. The numbers of patients, MRIs 
performed, and fractures diagnosed for each 
year are provided in Table 1. The anatomical dis-
tribution is shown in Table 2. The case-control 
study showed several risk factors, which were 
significantly more common in the case series. 
Older age, female gender, radiological erosions 
in hand/wrist, and treatment with methotrexate 
were all significantly associated with fractures. 
Other variables that were not associated with 
fractures included disease duration, positive 
results for rheumatoid factor or anti-citrullinat-
ed protein antibodies (ACPA), erosions in feet, 
DAS28crp, CRP, smoking, BMI, or use of pred-
nisolone or biologic Disease Modifying Anti-
rheumatic Drug (bDMARD). In the case series, 
the average age was 68 years, median disease 
duration was 12 years, and 93% were women. 
The average DAS28crp was 2.3, that indicates re-
mission. Comparison of the case series and the 
case-control group is provided in Table 3.
The estimated average annual minimum frac-
ture incidence rate over the study period was 
3.31 per 1000 years (32/(935+1005+1165+ 
1202+1276+1352+1351+1377 person years)). 
Only the first fracture episode was included 
in these incidence calculations, despite 20 pa-
tients suffering at least one more episode in 
the study period.
Clinical and radiological manifestations
The patients with fractures presented symp-
toms of slight, sudden onset pain in the 
knee, ankle/foot without any relevant trau-
ma. The onset of fracture symptoms was 
well described in all the patients’ medical 
records.
MRI was performed at a median of 84 days 
(18-948) after the estimated fracture date and 
with the same delay for knees and ankles/
feet. Among the 32 patients with fractures, 26 
patients had antecedent conventional radi-
ography, which could not detect the fracture 
(Figure 2). Despite conventional radiography 
initially being reported without fracture, three 
of them later gave evidence of a visible fracture 
when reviewed after the MRI had detected a 
fracture. Six patients with fractures were not 
examined by conventional radiography before 
MRI. One included a patient with a distal tibia 
fracture referred to, and registered as, MRI, but 
who instead had a CT scan because of a metal 
implant.
Among the 32 patients with fractures, 16 pa-
tients were treated with at least one intra-ar-
ticular steroid injection in the fractured joint 
before the fracture was diagnosed by MRI. Four 
of the 16 patients had two injections and one 
patient even had four.
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Table 1. For each year,  the total number of RA patients treated in the clinic by the end of each year, the number of MRIs performed, and the 
number of RA patients with a fracture have been noted. The last two columns display the period in days from onset of symptoms until fracture 
diagnosis by MRI. Owing to the small number of observations, the delay in days is stated as a range and only the last row as a calculated median.
   MRI performed Fracture present Delay diagnosis in days
Year RA clinic population Knee Ankle/foot Knee Ankle/foot Knee Ankle/foot
2010 935 3 3 3 2 32-214 85-241
2011 1,005 0 4 0 3 - 34-468
2012 1,165 5 5 2 4 197-249 216-948
2013 1,202 4 4 0 3 - 50-153
2014 1,276 3 8 0 4 - 30-652
2015 1,352 10 8 3 3 58-89 25-398
2016 1,351 3 2 1 0 105 -
2017 1,377 4 4 1 3 18 31-60
2010-2017 Average 1,208 (of 1,624 unique patients) 32 38 10 22 Median 84 Median 85
Table 2. Anatomical localization of the 39 fractures diagnosed with an MRI in the 32 unique 
patients (case series). In the cases with recurrent fracture episodes, only the first episode is 
included.
Fracture in  Knee Ankle Foot Multiple in 
anatomical region only only only ankle/foot
Distal femur 1 - - -
Proximal tibia 9 - - -
Distal tibia - 7 - 3
Talus - 3 - 3
Calcaneus - - 3 6
Naviculare/metatarsal - - 3 1
Number of fractures 10 10 6 13
Number of patients 10 10 6 6
Figure 2. a, b. Conventional radiography July 
2011 (a). MRI (T1) August 2011 (b). Only on 
MRI, the distal tibia insufficiency fracture is 
clearly visible.
a b
The patients’ fractures were treated conserva-
tively with an immobilization plaster for sev-
eral weeks. Twenty of the 32 patients with a 
fracture episode experienced at least one ad-
ditional fracture episode in the knee or ankle/
foot within the 8-year study period.
Risk factors of insufficiency fractures
The case-control study showed several 
risk factors, which were significantly more 
common in the case series. Older age, fe-
male gender, radiological erosions in hand/
wrist, and treatment with methotrexate 
were all significantly associated with frac-
tures. Other variables that were not associ-
ated with fractures included disease dura-
tion, positive results for rheumatoid factor 
or ACPA, erosions in feet, DAS28crp, CRP, 
smoking, BMI, and use of prednisolone or 
bDMARD. 
Osteoporosis (T score <-2.5) as measured by 
DEXA scans was compared between cases and 
controls and showed a statistically significant 
difference between the groups (Table 4). Pa-
tients with insufficiency fractures had signifi-
cantly lower T score values than the controls. 
Additionally, a diagnosis of osteoporosis was 
found to be statistically significant related to 
the occurrence of insufficiency fractures in our 
study population (p=0.027, Fisher test of con-
tingency).
Discussion
In this study, we demonstrate that new-on-
set knee or ankle/foot pain in patients with 
RA is frequently due to insufficiency fractures 
only visible on MRI scans. Most patients ex-
perienced significant delays in diagnosis and 
fracture treatment, resulting in long-term pain 
and disability. Twenty of the 32 patients (62%) 
experienced at least one additional fracture 
episode in the knee or ankle/foot in the 8-year 
study period. The minimum incidence rate of a 
first-time insufficiency fracture in the knee or 
ankle/foot was 3.31/1000 RA patients/year.
Additionally, we found an increased risk of frac-
ture in female patients, in older patients, and 
in patients with erosions of hand and wrist, 
in patients treated with methotrexate, and in 
patients with osteoporosis. In contrast, several 
other traditionally acknowledged risk factors 
could not be associated with fractures. 
Despite that osteoporosis was statistically and 
significantly associated with insufficiency frac-
tures in our study, only half of the patients with 
fractures had osteoporosis. These findings sup-
port both routine screening for osteoporosis in 
patients with RA and scrutiny for the diagnosis 
of fracture even if osteoporosis is absent.
The use of the unique patients’ ID system and 
the twice-a-year complete database registra-
tion coverage in a stable patient population 
ensured that no patient information was lost 
to follow-up. To date, the published case se-
ries of insufficiency fractures in patients with 
RA is very limited in number and principally 
based on conventional radiography without 
any long-term follow-up. The criteria used for 
making the case-control group reflect the clin-
ical situation presented to the rheumatologist 
when examining a patient with RA with local 
pain in the knee or ankle/foot.
Our study has some limitations, mostly with 
respect to underestimation of the true number 
of fractures. We did not retrieve fractures seen 
on conventional radiography and which were 
therefore not examined by MRI. The case series 
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Table 3. Characteristics of the 70 unique patients with RA who had an MRI of the knee or ankle/
foot during 2010-2017. 
 Fracture No fracture 
Variable (case series) (case-control group) p
No. of patients 32 38 -
Age (years) 68.5 (33-89) 62.5 (32-84) 0.011
RA duration (years) 12 (0-45) 10 (0-33) NS
Gender (No. of females/No. of males) 30/2 28/10 <0.0001
Anatomy MRI (knee, ankle/foot) Knee: 10 Ankle: 22 Knee: 23 Ankle: 15 -
IgM RF, pos/neg/unknown 25/7/0 29/9/0 NS
Anti-CCP, pos/neg/unknown 18/12/2 21/16/1 NS
Erosion upper extremity, +/- 17/15 11/27 0.04
Erosion lower extremity, +/- 16/16 11/27 NS
DAS28crp, median (range) 2.3 (1.6-6.6) 2.8 (1.3-6.1) NS
CRP (mg/L) 3 (1-46) 5 (1-64) NS
MTX treatment, +/- 31/1 29/9 0.014
MTX treatment duration years 6 (0-20) 5 (0-20) NS
bDMARD, +/- 4/28 1/37 NS
Smoking, yes/stopped/never 9/10/13 11/8/19 NS
BMI (kg/m2), median (range) 24.5 (18-41) 27 (20-36) NS
NS denotes no statistical difference between groups.
Table 4. Number of patients with, or without, fracture with presence, or absence, of osteoporosis. 
DEXA scan results were not available for 15 patients. Osteoporosis was defined as a DEXA scan 
result <-2.5.
Result of  Fracture No fracture 
DEXA scans (case series) (case-control group) p 
Osteoporosis present 15 5 0.027 
 (12 in treatment) (5 in treatment) (Fisher’s exact test)
No osteoporosis 15 20 
DEXA T score, median (range) -2.48  -1.42 0.0047
 (-4.13 to 0.50) (-5.0 to 0.54) (Mann-Whitney Test)
No DEXA scan available 2 13 -
Use of prednisolone, actual/ever/never 7/26/6 5/23/14 NS
Osteoporosis treatment, yes/no 12/3 5/1 NS
Osteoporosis treatment duration (years) 3 (0-8) 3 (0-11) NS
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comprised 39 fractures in 32 unique patients, 
and only the first episode was included. If all the 
fractures had been included, including the later 
fracture episodes, the fracture incidence rate 
would have increased significantly. Our review 
of original MRI radiological reports excluded 
the possibility of false positives, but false neg-
atives (failure to report a fracture) may exist (10, 
11). MRI capacity is frequently limited; clinicians 
therefore try to limit the number of referrals, 
and this reluctance may explain the high “hit 
rate” of 46% with a fracture. The number of our 
patients with an MRI-incompatible metal is low, 
this tends to underestimate the number of frac-
tures detectable only by MRI. The uneven num-
bers (range 4-18) of MRIs performed by year 
may indicate the staff’s shifting awareness of 
insufficiency fractures. Furthermore, it is possi-
ble that the true fracture incidence is higher be-
cause RA patients with a new onset of knee or 
ankle pain, and a normal conventional radiog-
raphy or DEXA scan, are less likely to be referred 
to an MRI examination. The missing DEXA scans 
for the control group may weaken the statisti-
cal significance. Finally, we cannot exclude as-
ymptomatic cases, or unwillingness to report 
symptoms, although it seems unlikely from a 
clinical point of view and from a viewpoint of 
easy access to free care in the clinic.
The anatomical sites of the insufficiency frac-
tures in our case series, their clinical presenta-
tions, and the effects on the patients are similar 
to those seen in other, but smaller studies (8, 
13). Consistent with a previously unreported 
finding, we have shown that insufficiency frac-
tures are commonly a recurrent problem be-
cause 62% of the patients experienced at least 
one more subsequent insufficiency fractures, 
either in the same place or elsewhere in the 
knees or ankles/feet.
A study from 1995 to 1999 examined 33 pa-
tients with inflammatory joint disease and in-
sufficiency fractures (14). For 26 patients, the 
fractures were located in, or below, the knee 
and mostly in the metatarsal bones. MRI was 
only used for some selected cases with cal-
caneal pain. The patients were generally sig-
nificantly younger, with an average age of 44 
years. However, the description of the clinical 
presentations of fractures corresponds well 
with our findings.
An epidemiological study examined the in-
cident first-time fractures in 1008 female pa-
tients with RA in an 8-year period from 1994 
to 2001 (2). By conventional radiography, 82 
fractures were diagnosed, of which 15 were in, 
or distal to, the knee and 26 in the spine. The 
relative risk of any incident first-time fracture 
for patients with RA was 1.43 (95% CI 0.98-2.09) 
compared to the general population.
A retrospective study of 2,250 patients with 
RA from 1990 to 1999 found 18 patients with 
stress fractures, of which 11 were in the knee, 
ankle, or foot (8). The fractures were diagnosed 
using conventional radiography and, in one 
patient, using isotope bone scan. The delay 
of diagnosis was a median of 4 (range 1-12) 
weeks. Ongoing, and high-dose, treatment 
with corticosteroids was more common in 
patients with fractures than that in controls. 
Osteoporosis was not found to be a risk factor. 
Clinical presentation of fractures and delays in 
diagnosis correspond to our findings.
A study prospectively examined 209 patients 
with RA for possible fractures in a 1-year period 
with four scheduled examinations by an ortho-
pedic surgeon who frequently used either con-
ventional radiography, CT, MRI, or bone scans 
(13). Most patients were in current long-term 
treatment with corticosteroids, but no other 
treatments were explained. They found five 
cases with insufficiency fractures in the knee or 
ankle/foot. This number is significantly higher 
than expected from our study and probably 
explained by patients with a more severe dis-
ease, a high prevalence of previous joint sur-
gery, and careful search for even minor pain 
problems indicating a fracture. 
The inclusion criteria we used for both the case 
series and the control group may explain why 
our findings differ from those of other stud-
ies. We consequently used first-time MRI for 
diagnosis and did not use any other types of 
radiography. We selected our control group 
to most accurately mimic the clinical presen-
tation of patients with RA with insufficiency 
fractures consulting a rheumatologist.
Knees, ankles, and feet are weight-bearing 
joints and commonly deformed in RA. These 
conditions, together with the increased inci-
dence of reduced bone strength in patients 
with RA, are some of the possible risk factors 
for insufficiency fractures or stress fractures. 
Corticosteroid treatment may predispose such 
patients to insufficiency fractures rather than 
disease-specific factors such as RA disease ac-
tivity or duration, a suggestion supported by 
others (8-12). However, stress fractures in RA 
were also reported before the introduction 
of corticosteroid treatment (18). We may also 
speculate whether patients with RA have lo-
calized reduced bone mass around their joints 
corresponding to the halisteresis around joints 
commonly observed by conventional radiog-
raphy. 
Some studies have suggested a causal relation-
ship between insufficiency fractures and the 
use of methotrexate (19, 20), while others have 
not been able to find such a correlation (15). Our 
case-control study found that treatment with 
methotrexate was significantly associated with 
fractures but not with the duration of the treat-
ment. This might support the belief that there is 
a causal relationship. However, in our clinical ex-
perience, we have not seen this type of fracture 
in patients treated with methotrexate for other 
common joint diseases, e.g., psoriatic arthritis.
Insufficiency fractures in knees, ankles, or feet 
are not uncommon and are most likely even 
found to be more frequent if the physicians are 
more aware of the diagnosis and clinical pre-
sentation. Hopefully, more awareness can lead 
to fewer delays in the diagnosis and avoidance 
of potential harmful treatments.
We do not fully understand why patients with 
RA suffer from unusual fractures. Osteoporosis 
is a risk factor, but half of the patients with frac-
tures had no osteoporosis. We do not know an 
effective way to prevent these fractures, and 
especially one to avoid the high rate of subse-
quent insufficiency fractures in knees, ankles, 
and feet. Different types of osteoporosis med-
ication work differently in different anatomical 
regions (spine, hip, radius, and tibia). We there-
fore do not know what type of medicine will be 
effective after a fracture in the knee or ankle/
foot to prevent new fractures (21). Treatment 
of, and rehabilitation after, these fractures is 
complex, e.g., difficulties in using crutches and 
wheelchairs because of hand or wrist prob-
lems. The necessary period for no weight load 
during plastering is not clear and the time for 
definite fracture healing is difficult to ascertain. 
All the above-mentioned unanswered ques-
tions call for more research.
In conclusion, a diagnosis of insufficiency frac-
ture should be considered in elderly female pa-
tients with RA who present with unexplained 
lower extremity joint pain and MRI should be 
performed even if the initial conventional ra-
diographs and DEXA scans are normal. 
Ethics Committee Approval: No ethical approval was 
needed in Denmark for this type of study. Instead 
the study has been approved by the local data pro-
tection agency, North Denmark Region Research 
Administration. (Approval Date: October 1, 2018; Ap-
proval Number: 2018-155).
Informed Consent: Written informed consent was not 
obtained due to the nature of the study.
Peer-review: Externally peer-reviewed. 
Author Contributions: Concept - A.Y., S.K.F., C.R.; De-
sign - A.Y., S.K.F., C.R.; Supervision - A.Y., S.K.F., C.R.; 
Materials - A.Y., S.K.F., C.R.; Data Collection and/or 
Processing - A.Y., S.K.F., C.R.; Analysis and/or Interpre-
tation - A.Y., S.K.F., C.R.; Literature Search - A.Y., S.K.F., 
C.R.; Writing Manuscript - A.Y., S.K.F., C.R.; Critical Re-
view - A.Y., S.K.F., C.R.
Conflict of Interest: The authors have no conflicts of 
interest to declare. 
Financial Disclosure: The authors declared that this 
study has received no financial support.
References
1. Michaud K, Wolfe F. Comorbidities in rheuma-
toid arthritis. Best Pract Res Clin Rheumatol 
2007; 21: 885-906. [Crossref]
2. Brennan SL, Toomey L, Kotowicz MA, Henry MJ, 
Griffiths H, Pasco JA. Rheumatoid arthritis and 
incident fracture in women: A case-control 
study. BMC Musculoskelet Disord 2014; 15: 13. 
[Crossref]
3. Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang 
CL, Garneau K, et al. Risk of osteoporotic frac-
ture in a large population-based cohort of pa-
tients with rheumatoid arthritis. Arthritis Res 
Ther 2010; 12: R154. [Crossref]
4. Resnick D, Cone R. Pathological fractures in 
rheumatoid arthritis. RadioGraphics 1984; 4: 
549-62. [Crossref]
5. Hauser B, Riches PL, Wilson JF, Horne AE, Ralston 
SH. Prevalence and clinical prediction of oste-
oporosis in a contemporary cohort of patients 
with rheumatoid arthritis. Rheumatology 2014; 
53: 1759-66. [Crossref]
6. Spina A, Clemente A, Vancini C, Fejzo M, Campi-
oni P. Spontaneous talar and calcaneal fracture 
in rheumatoid arthritis: A case report. J Radiol 
Case Rep 2011; 5: 15-23. [Crossref]
7. Pentecost RL, Murray RA, Brindley HH. Fatigue, 
insufficiency, and pathologic fractures. JAMA 
1964; 187: 1001-4. [Crossref]
8. Kay L, Holland T, Platt P. Stress fractures in rheu-
matoid arthritis: A case series and case-con-
trol study. Ann Rheum Dis 2004; 63: 1690-2. 
[Crossref]
9. Fam AG, Shuckett R, McGillivray DC, Little AH. 
Stress fractures in rheumatoid arthritis. J Rheu-
matol 1983: 10: 722-6.
10. Schneider R, Kaye JJ. Insufficiency and stress 
fractures of the long bones occurring in pa-
tients with rheumatoid arthritis. Radiology 
1975; 116: 595-9. [Crossref]
11. Dreher R, Buttgereit F, Demary W, Görtz B, Hein 
G, Kern P, et al. Insufficiency fractures in rheu-
matology. Case report and overview. Z Rheu-
matol 2006; 65: 417-23. [Crossref]
12. Elkayam O, Paran D, Flusser G, Wigler I, Yaron 
M, Caspi D. Insufficiency fractures in rheumatic 
patients: Misdiagnosis and underlying charac-
teristics. Clin Exp Rheumatol 2000; 18: 369-74.
13. Nampei A, Hashimoto J, Koynagi J, Ono T, 
Hashimoto H, Tsumaki N, et al. Characteristics 
of fracture and related factors in patients with 
rheumatoid arthritis. Modern Rheumatol 2008; 
18: 2, 170-6. [Crossref]
14. Mäenpää HM, Soini I, Lehto MUK, Belt EA. In-
sufficiency fractures in patients with chronic 
inflammatory joint diseases. Clin Exp Rheum 
2002; 20: 77-9.
15. Vestergaard P, Rejnmark L, Mosekilde L. Meth-
otrexate, azathioprine, cyclosporine, and risk 
of fracture. Calcif Tissue Int 2006; 79: 69-75. 
[Crossref]
16. Sankey RA, Turner J, Lee J, Healy J, Gibbons CE. 
The use of MRI to detect occult fractures of the 
proximal femur: A study of 102 consecutive cas-
es over a ten-year period. J Bone Joint Surg Br 
2009; 91: 1064-8. [Crossref]
17. Ibfelt EH, Sørensen J, Jensen DV, Dreyer L, 
Schiøttz-Christensen B, Thygesen PH, et al. Va-
lidity and completeness of rheumatoid arthritis 
diagnoses in the nationwide DANBIO clinical 
register and the Danish National Patient Regis-
try. Clin Epidemiol 2017; 9: 627-32. [Crossref]
18. Boer GJ. Fractures in chronic arthritis. Ann 
Rheum Dis 1941; 2: 269-73. [Crossref]
19. Schapira D, Scharf Y. Insufficiency fracture of the 
distal tibia mimicking arthritis in a rheumatoid 
arthritis patient. The possible role of methotrex-
ate treatment. Clinical Exp Rheumatol 1995; 31: 
130-1.
20. Van der Bijl AE, Zijlstra TR, Engelage AH, Post-
huma BJ, van Veen GJ. [Three patients with a 
fracture during methotrexate use, possibly due 
to methotrexate osteopathy]. Ned Tijdschr Ge-
neeskd 2008; 152: 2357-60.
21. Lems WF, Dreinhöfer KE, Bischoff-Ferrari H, 
Blauth M, E Czerwinski, Silva JAP, et al. EULAR/
EFORT recommendations for management of 
patients older than 50 years with a fragility frac-
ture and prevention of subsequent fractures. 
Ann Rheum Dis 2017; 76: 802-10. [Crossref]
129
Eur J Rheumatol 2020; 7(3): 124-9 Yurtsever et al. Insufficiency fractures of knee and ankle
